Live feed07:00:00·720dPRReleasevia QuantisnowSyros to Host Webcast Event on Higher-Risk Myelodysplastic Syndrome and the Opportunity for Tamibarotene to Become the New Frontline Standard-of-Care for Patients with RARA Gene OverexpressionByQuantisnow·Wall Street's wire, on your screen.SYRS· Syros Pharmaceuticals Inc.Health Care
